Pedro Torres‐Ayuso

828 total citations
20 papers, 406 citations indexed

About

Pedro Torres‐Ayuso is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Pedro Torres‐Ayuso has authored 20 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Pedro Torres‐Ayuso's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Protein Degradation and Inhibitors (3 papers). Pedro Torres‐Ayuso is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Protein Degradation and Inhibitors (3 papers). Pedro Torres‐Ayuso collaborates with scholars based in United States, Spain and United Kingdom. Pedro Torres‐Ayuso's co-authors include Isabel Mérida, Antonia Ávila‐Flores, John Brognard, María Tello‐Lafoz, Katherine M. Nyswaner, Jorge Martı́n-Pérez, Manuel Daza-Martín, Severine Gharbi, Eleanor W. Trotter and Esther Rincón and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Applied and Environmental Microbiology.

In The Last Decade

Pedro Torres‐Ayuso

20 papers receiving 403 citations

Peers

Countries citing papers authored by Pedro Torres‐Ayuso

Since Specialization

Citations

This map shows the geographic impact of Pedro Torres‐Ayuso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Torres‐Ayuso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Torres‐Ayuso more than expected).

Fields of papers citing papers by Pedro Torres‐Ayuso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Torres‐Ayuso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Torres‐Ayuso. The network helps show where Pedro Torres‐Ayuso may publish in the future.

Co-authorship network of co-authors of Pedro Torres‐Ayuso

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Torres‐Ayuso. A scholar is included among the top collaborators of Pedro Torres‐Ayuso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Torres‐Ayuso. Pedro Torres‐Ayuso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy 2024 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Nick Connis, (unknown), Jinhee Chang, (unknown), Amol C. Shetty, Yang Song, (unknown), (unknown), (unknown), Muhammad Ajmal Khan, Kathleen L. Gabrielson, (unknown), Pedro Torres‐Ayuso, John Brognard, Christine L. Hann, Phuoc T. Tran	3
2	Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Venkata R. Sabbasani, (unknown), Pedro Torres‐Ayuso, Katarzyna Wróbel, (unknown), Remigiusz Serwa, Rolf E. Swenson, John Brognard, Anna A. Marusiak	5
3	PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer 2023 ·Cell chemical biology ·Pedro Torres‐Ayuso, Meghri Katerji, (unknown), (unknown), Venkata R. Sabbasani, Hope Liou, (unknown), Shailender S. Chauhan, Remigiusz Serwa, (unknown), Anna A. Marusiak, Rolf E. Swenson, Noel A. Warfel, John Brognard	6
4	Degraders: The Ultimate Weapon Against Amplified Driver Kinases in Cancer 2022 ·Molecular Pharmacology ·Pedro Torres‐Ayuso, John Brognard	10
5	TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin 2021 ·Cancer Discovery ·Pedro Torres‐Ayuso, (unknown), Katherine M. Nyswaner, (unknown), Daniel A. Ritt, Suzanne I. Specht, Sudipto Das, Þorkell Andrésson, Raúl E. Cachau, Roger J. Liang, (unknown), Christina M. Robinson, Simone Difilippantonio, (unknown), Laura Bassel, Baktiar Karim, Chad J. Miller, Benjamin E. Turk, Deborah K. Morrison, John Brognard	38
6	Penicillin Acylase from Streptomyces lavendulae and Aculeacin A Acylase from Actinoplanes utahensis: Two Versatile Enzymes as Useful Tools for Quorum Quenching Processes 2020 ·Catalysts ·(unknown), Daniel Hormigo, Jesús Fernández‐Lucas, Pedro Torres‐Ayuso, (unknown), Ana Saborido, (unknown), José L. Garcı́a, Fernando Ramón, Carmen Acebal, Antonio Santos, Miguel Arroyo, Isabel de la Mata	14
7	The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells 2020 ·Journal of Biological Chemistry ·Van T. Hoang, Katherine M. Nyswaner, Pedro Torres‐Ayuso, John Brognard	17
8	Diacylglycerol Kinase Malfunction in Human Disease and the Search for Specific Inhibitors 2019 ·Handbook of experimental pharmacology ·Isabel Mérida, (unknown), Pedro Torres‐Ayuso, Antonia Ávila‐Flores	14
9	Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets 2019 ·Cancers ·Pedro Torres‐Ayuso, John Brognard	7
10	Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin 2018 ·npj Genomic Medicine ·Pedro Torres‐Ayuso, Sudhakar Sahoo, Garry Ashton, (unknown), Nicole Simms, Melanie Galvin, Hui Sun Leong, Kristopher K. Frese, Kathryn Simpson, Natalie Cook, Andrew Hughes, Crispin Miller, Richard Marais, Caroline Dive, Matthew Krebs, John Brognard	4
11	Survival of Head and Neck Cancer Cells Relies upon LZK Kinase-Mediated Stabilization of Mutant p53 2017 ·Cancer Research ·(unknown), Eleanor W. Trotter, Pedro Torres‐Ayuso, (unknown), Henry M. Wood, Katherine M. Nyswaner, John Brognard	24
12	Diacylglycerol kinases in cancer 2016 ·Advances in Biological Regulation ·Isabel Mérida, Pedro Torres‐Ayuso, Antonia Ávila‐Flores, (unknown), (unknown), María Tello‐Lafoz, (unknown), (unknown)	59
13	Somatically mutated ABL 1 is an actionable and essential NSCLC survival gene 2016 ·EMBO Molecular Medicine ·(unknown), Natalie L. Stephenson, Pedro Torres‐Ayuso, Anna A. Marusiak, Eleanor W. Trotter, Andrew Hudson, Cassandra L. Hodgkinson, Christopher J. Morrow, Caroline Dive, John Brognard	20
14	Diacylglycerol kinase-ζ regulates mTORC1 and lipogenic metabolism in cancer cells through SREBP-1 2015 ·Oncogenesis ·Pedro Torres‐Ayuso, María Tello‐Lafoz, Isabel Mérida, (unknown)	30
15	Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src 2014 ·Oncotarget ·Pedro Torres‐Ayuso, Manuel Daza-Martín, Jorge Martı́n-Pérez, Antonia Ávila‐Flores, Isabel Mérida	41
16	A Blk–p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion 2014 ·Cellular Signalling ·Rubén A. Bartolomé, Marta Díaz‐Martínez, Georgina P. Coló, (unknown), Pedro Torres‐Ayuso, Jan Willem Kleinovink, Isabel Mérida, Joaquı́n Teixidó	9
17	FoxO-Dependent Regulation of Diacylglycerol Kinase α Gene Expression 2012 ·Molecular and Cellular Biology ·Mónica Martínez‐Moreno, (unknown), (unknown), Pedro Torres‐Ayuso, (unknown), Xiao‐Ping Zhong, Gary A. Koretzky, Isabel Mérida, Antonia Ávila‐Flores	31
18	Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse 2011 ·Molecular Biology of the Cell ·Severine Gharbi, Esther Rincón, Antonia Ávila‐Flores, Pedro Torres‐Ayuso, (unknown), (unknown), Juan Pablo Albar, Isabel Mérida	41
19	Diacylglycerol kinase alpha, from negative modulation of T cell activation to control of cancer progression 2009 ·Advances in Enzyme Regulation ·Isabel Mérida, Antonia Ávila‐Flores, (unknown), Ernesto Merino, (unknown), Pedro Torres‐Ayuso	13
20	Newly Discovered Penicillin Acylase Activity of Aculeacin A Acylase from Actinoplanes utahensis 2007 ·Applied and Environmental Microbiology ·Jesús Torres‐Bacete, Daniel Hormigo, (unknown), Miguel Arroyo, Pedro Torres‐Ayuso, (unknown), Carmen Acebal, José L. Garcı́a, Isabel de la Mata	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact